Published company evidence
Read the context behind each recommendation, including the study it came from and the limits of what the evidence can show.
272 published fit reviews
Symetra is a mixed-to-good fit for Life Insurance After Prostate Cancer, not a clear best-in-class winner. Two of the seven platforms in this study named Symetra during the ranking stage, giving it a 28.6% share of included platform responses, an average listed rank of 3.5, and a best listed rank of 3.
Banner Life Insurance Company is a good, case-dependent fit for Life Insurance After Prostate Cancer, but only through full medical underwriting. Two of the seven platforms in this study named Banner during the ranking stage, and both placed it in their top four.
John Hancock is a mixed-to-good fit for Life Insurance After Prostate Cancer, not a proven best choice. Three of seven platforms named John Hancock during the ranking stage (google, kimi, perplexity), and it finished sixth overall with an average listed rank of 3.0 and a best rank of 1.
Protective Life is a mixed-to-good fit for Life Insurance After Prostate Cancer, depending on how the buyer weighs underwriting transparency against product flexibility. Four of the seven platforms in this study named Protective Life during the ranking stage — a 57% share — and its average listed rank was 4.5, with a…
Corebridge Financial is a mixed fit for Life Insurance After Prostate Cancer. Four of the seven platforms in this study named Corebridge during the ranking stage, and six of seven returned a usable fit assessment.
Prudential is a good, case-dependent fit for individually underwritten term or universal life after prostate cancer, but not a guaranteed-acceptance option. Its underwriting guide contemplates prostate cancer histories, and term policies convert to permanent coverage.
Lincoln Financial is a good, case-dependent fit for Life Insurance After Prostate Cancer, not a guaranteed one. Six of seven platforms named it during the ranking stage, and it finished second overall with an average listed rank of 4.17 and a best rank of 1.
Mutual of Omaha is a good fit for a prostate-cancer survivor who needs guaranteed-acceptance or simplified-issue coverage, especially for final expenses, but it is not clearly the best first choice for large death benefits. Its guaranteed-issue whole life requires no medical exam or health questions for eligible ages.
Symetra is a mixed-to-good fit for life insurance after breast cancer, not a confirmed specialist. Its fully underwritten term products and possible rate reconsideration may help survivors, but no breast-cancer-specific underwriting grid or survivor pricing is published.
Haven Life (MassMutual) is a mixed fit for Life Insurance After Breast Cancer. Three of seven platforms named it during the ranking stage (43% of included platform responses), at an average listed rank of 7.7 and a best listed rank of 5.
Physicians Mutual is a good fit for a breast cancer survivor who needs modest permanent final-expense coverage and cannot or does not want to answer health questions. Three of seven platforms named it during the ranking stage (43% of included platform responses), at an average listed rank of 7.3 and a best rank of 6.
Protective is a mixed fit for life insurance after breast cancer. It publicly states survivors can qualify and one review calls rates competitive after five years in remission, but it publishes no breast-cancer-specific underwriting schedule, waiting period, or survivor pricing.
